The Discounted Cash Flow (DCF) valuation of Harrow Health Inc (HROW) is (84.27) USD. With the latest stock price at 34.93 USD, the upside of Harrow Health Inc based on DCF is -341.3%.
Based on the latest price of 34.93 USD and our DCF valuation, Harrow Health Inc (HROW) is a sell. selling HROW stocks now will result in a potential gain of 341.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.6% | 8.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (168.61) - (57.56) | (84.27) |
| Upside | -582.7% - -264.8% | -341.3% |